Transcranial Magnetic Stimulators Market

Transcranial Magnetic Stimulators Market (Product Type: Repetitive TMS, Deep TMS, and Others; Application: Therapeutics, Research, and Diagnostics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Global Transcranial Magnetic Stimulators Market Outlook 2031

  • The industry was valued at US$ 216.9 Mn in 2022
  • It is projected to grow at a CAGR of 7.2% from 2023 to 2031 and reach more than US$ 413.7 Mn by the end of 2031

Analyst Viewpoint

Increase in awareness and rise in acceptance are driving the global transcranial magnetic stimulators market. Surge in incidence of neurological and psychiatric disorders such as depression, anxiety, Parkinson's disease, and chronic pain has spurred the need for safe and efficient treatment methods. Ongoing research and trials exploring transcranial magnetic stimulator (TMS) applications in broader disorders beyond its traditional scope are propelling market expansion. Furthermore, introduction of advanced technologies in TMS to address neurological disorders is expected to bolster the global transcranial magnetic stimulators industry size during the forecast period.

Expansion of applications of transcranial magnetic stimulators market offer lucrative opportunities to market players. Companies are focusing on introducing TMS systems with enhanced precision, personalized treatment algorithms, and innovative simulation techniques in order to increase market share.

Transcranial Magnetic Stimulators Market

Global Transcranial Magnetic Stimulators Market Overview

Transcranial magnetic stimulators are devices that utilize non-invasive magnetic pulses to stimulate specific brain regions, primarily for therapeutic purposes in neurological and psychiatric disorders.

These tools create electrical currents in the brain, adjusting neural activity to potentially alleviate conditions such as depression, anxiety, and chronic pain. Recent innovations in transcranial magnetic stimulation (TMS) technology involve inventive coil designs, precise systems for targeted therapy, and upgraded software for accurate customization.

These enhancements enable deeper brain stimulation, enhance treatment effectiveness, and allow for real-time adjustments during therapy sessions. Additionally, incorporation of advanced navigation systems and neuroimaging techniques results in more exact and personalized applications of TMS.

Increase in Awareness and Rise in Acceptance of TMS Driving Market Development

Increase in awareness about TMS among both medical practitioners and patients is enhancing its reputation as a safe and non-invasive therapy. TMS has attracted attention for its ability to regulate brain activity using magnetic pulses, showing promise in alleviating symptoms associated with a range of neurological disorders such as depression, anxiety, Parkinson's disease, and chronic pain.

Rise in scientific evidence supporting the effectiveness of TMS across various neurological conditions is enhancing its acceptance among patients seeking alternative treatments and healthcare professionals exploring non-pharmaceutical therapies.

Surge in clinical research is reinforcing the robust clinical evidence supporting the effectiveness of TMS, fostering confidence among healthcare professionals and expanding its integration into treatment protocols. This validation is making TMS a more widely accepted therapeutic choice.

TMS is no longer confined to depression; ongoing studies exploring its potential for conditions such as addiction, migraines, and stroke are broadening its applicability to diverse patient groups, thus extending its impact and market potential.

For instance, a 2023 meta-analysis published in JAMA Psychiatry provided further evidence of TMS's effectiveness in treating major depressive disorder, reinforcing its clinical validity.

Introduction of Advanced Technologies in TMS to Address Neurological Disorders

Cutting-edge advancements are revolutionizing transcranial magnetic stimulation (TMS), elevating its accuracy, effectiveness, and versatility in treating diverse neurological conditions. These breakthroughs involve sophisticated TMS systems equipped with more precise targeting capabilities, personalized treatment algorithms, and innovative stimulation patterns.

Advancements in coil designs, navigational tools, and neuroimaging techniques enable a tailored and responsive application of TMS therapy, maximizing its therapeutic capabilities. This technological progression signifies substantial strides in the realm of transcranial magnetic stimulation (TMS), ushering in novel treatment opportunities and fostering market expansion.

For instance, precision-guided coils, such as the focUS coil from NeuroStar NexGen, effectively zero in on specific brain regions, enhancing the impact of stimulation. Similarly, devices such as NeuroField's Freedom TMS Pro offer real-time feedback, facilitating personalized adjustments during therapy for improved outcomes. Notably, the debut of BrainsWay's Deep TMS X4 in 2023 promises access to deeper brain structures, potentially aiding conditions such as Parkinson's disease and addiction.

These innovations broaden the scope of TMS applications beyond conventional uses, catering to a wider array of conditions. For instance, Brainscope's FDA-cleared Flow HD 2 device introduces a non-invasive approach to managing chronic pain, while tools, such as Magstim's Theta Burst TMS, exhibit potential in stroke rehabilitation through ongoing clinical trials.

By integrating these advanced technologies, TMS not only enhances treatment efficacy, but also expands its potential in addressing a broader spectrum of neurological disorders, thereby propelling the transcranial magnetic stimulators market growth.

Innovative Methodology and Effectiveness Fueling Demand for Deep TMS

In terms of product type, the deep TMS segment dominated the global transcranial magnetic stimulators market in 2022. This can be ascribed to its innovative methodology and effectiveness in treating a broad range of neurological conditions.

This technique involves a specialized coil design within a padded helmet, enabling precise stimulation of deeper brain regions that were previously hard to reach using traditional TMS approaches. This innovation has attracted attention for its potential in addressing psychiatric and neurological disorders, including major depressive disorder, obsessive-compulsive disorder, and addiction.

The capability to target these deeper brain areas broadens the scope of treatable conditions, while the increasing clinical evidence supporting its efficacy contributes to its adoption. Leading companies such as BrainsWay are pioneering these cutting-edge solutions. These factors are projected to drive the global transcranial magnetic stimulators market demand in the near future.

Broad Range of Applications Fueling Demand for TMS in Therapeutics

Based on application, the therapeutic segment accounted for the largest global transcranial magnetic stimulators market share in 2022. This is ascribed to its broad range of applications in managing diverse neurological and psychological disorders.

TMS has proven effective in addressing conditions such as depression, anxiety, obsessive-compulsive disorder (OCD), Parkinson's disease, and chronic pain. Its non-invasive methodology, employing magnetic pulses to modulate brain activity, offers a compelling alternative to traditional treatments.

Robust clinical research supporting TMS efficacy across various conditions, as highlighted by the National Institutes of Health (NIH) citing response rates of 30% to 50% in depression treatment compared to 20% to 40% with medications alone, contributes to the growing acceptance and adoption of TMS in therapeutic settings. This expanding body of evidence underscores TMS's viability and significantly influences market perceptions and uptake.

Regional Outlook

As per transcranial magnetic stimulators market analysis, North America dominated the global industry in 2022. This is ascribed to well-established healthcare system and robust insurance coverage for TMS therapy.

However, North America grapples with high incidence of neurological and psychiatric disorders such as depression, anxiety, and chronic pain, creating a larger potential market for TMS therapy and consequently driving its adoption and market growth.

According to statistics from the National Institute of Mental Health, over 21 million adults in the U.S. experience at least one major depressive episode annually. The country has a history of pioneering medical technology adoption, including TMS, which stemmed from early research and clinical trials.

Initiatives such as the U.S. National Institutes of Health BRAIN Initiative and FDA regulations provide crucial infrastructure and research funding, fostering confidence and expediting innovation within the region.

Countries in Europe are promoting awareness about TMS therapy, which is resulting in rise in patient demand and acceptance of this treatment. Moreover, efforts to expand insurance coverage and encourage the integration of TMS into clinical practice have made it more accessible throughout the continent.

Supportive healthcare policies, increase in awareness among healthcare professionals and patients, as well as favorable reimbursement policies in select countries in Europe, have facilitated the widespread adoption of TMS in the region.

With depression affecting over 84 million people in Europe, TMS emerges as a valuable therapeutic choice. The release of updated guidelines for TMS usage by the European Society for Clinical Neurophysiology in October 2023 signifies the increasing acceptance and standardization of TMS within the medical community.

As per transcranial magnetic stimulators market research, Asia Pacific, with its substantial population, particularly in countries such as China and India, presents significant market potential for TMS therapy.

According to the World Health Organization, more than 60 million people in Asia Pacific are affected by depression, emphasizing the pressing need for effective treatments such as TMS. Additionally, prevalent neurological conditions such as Parkinson's disease and chronic pain contribute to the potential applications of TMS in this region.

Economic development in Asia Pacific is leading to increased healthcare spending, fostering the adoption of advanced medical technologies such as TMS and facilitating the expansion of the market in the region.

Analysis of Key Players

The global transcranial magnetic stimulators market is fragmented, with the presence of large number of players. Manufacturers are adopting strategies such as investment in R&D and merger & acquisition to increase market share.

Neurosoft, Magstim, Nexstim plc, MagVenture, Inc., BrainsWay, Seber Medical, and Soterix Medical, Inc. are the prominent players in the market.

Key Developments in Global Transcranial Magnetic Stimulators Industry

  • In October 2023, Neurosoft partnered with a consortium of European research institutions to conduct a clinical trial investigating the use of rTMS for chronic pain management.
  • In April 2023, Nexstim plc introduced NBS 6, a new software generation for navigated transcranial magnetic stimulation (nTMS) systems in the U.S. This latest version, NBS 6, facilitates the utilization of Nexstim’s distinctive E-field navigated TMS technology in a more user-friendly manner than previous iterations.

Leading players in the biliary stents market report have been profiled based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and latest developments.

Global Transcranial Magnetic Stimulators Market Snapshot

Attribute Detail
Size in 2022 US$ 216.9 Mn
Forecast (Value) in 2031 More than US$ 413.7 Mn
Growth Rate (CAGR) 7.2%
Forecast Period 2023-2031
Historical Data Available for 2017-2021
Quantitative Units US$ Mn for Value
Market Analysis It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.
Competition Landscape
  • Market share analysis by company (2022)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials
Format Electronic (PDF) + Excel
Segmentation
  • Product Type
    • Repetitive TMS
    • Deep TMS
    • Others (Express TMS, ppTMS, etc.)
  • Application
    • Therapeutics
    • Diagnostics
    • Research
  • End-user
    • Hospitals
    • Specialty Centers
    • Others (research centers, academics, etc.)
Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • France
  • Germany
  • U.K.
  • Italy
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa
Companies Profiled
  • Neurosoft
  • Magstim
  • Nexstim plc
  • MagVenture, Inc.
  • BrainsWay
  • Seber Medical
  • Soterix Medical, Inc.
Customization Scope

Available upon request

Pricing

Available upon request

Frequently Asked Questions

How big was the global transcranial magnetic stimulators market in 2022?

It was valued at US$ 216.9 Mn in 2022

How big will the transcranial magnetic stimulators business be in 2031?

It is projected to reach more than US$ 413.7 Mn by 2031

What will be the CAGR of the transcranial magnetic stimulators industry during the forecast period?

It is anticipated to be 7.2% from 2023 to 2031

Which region will account for major share the transcranial magnetic stimulators sector during the forecast period?

North America is expected to account for the largest share from 2022 to 2031

Who are the prominent manufacturers of transcranial magnetic stimulators?

Neurosoft, Magstim, Nexstim plc, MagVenture, Inc., BrainsWay, Seber Medical, and Soterix Medical, Inc.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Transcranial Magnetic Stimulators Market

4. Market Overview

    4.1. Introduction

        4.1.1. Market Definition

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Transcranial Magnetic Stimulators Market Analysis and Forecast, 2017–2031

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Regulatory Scenario

    5.2. Prevalence rate of various Neurodisorders by region/country

    5.3. Technological Advancements

6. Global Transcranial Magnetic Stimulators Market Analysis and Forecast, by Product Type

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Product Type, 2017–2031

        6.3.1. Repetitive TMS

        6.3.2. Deep TMS

        6.3.3. Others

    6.4. Market Attractiveness Analysis, by Product Type

7. Global Transcranial Magnetic Stimulators Market Analysis and Forecast, by Application

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by Application, 2017–2031

        7.3.1. Therapeutics

        7.3.2. Diagnostics

        7.3.3. Research

    7.4. Market Attractiveness Analysis, by Application

8. Global Transcranial Magnetic Stimulators Market Analysis and Forecast, by End-user

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Market Value Forecast, by End-user, 2017–2031

        8.3.1. Hospitals

        8.3.2. Specialty Centers

        8.3.3. Others (research centers, academics, etc.)

    8.4. Market Attractiveness Analysis, by End-user

9. Global Transcranial Magnetic Stimulators Market Analysis and Forecast, by Region

    9.1. Key Findings

    9.2. Market Value Forecast, by Region

        9.2.1. North America

        9.2.2. Europe

        9.2.3. Asia Pacific

        9.2.4. Latin America

        9.2.5. Middle East & Africa

    9.3. Market Attractiveness Analysis, by Region

10. North America Transcranial Magnetic Stimulators Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast, by Product Type, 2017–2031

        10.2.1. Repetitive TMS

        10.2.2. Deep TMS

        10.2.3. Others

    10.3. Market Value Forecast, by Application, 2017–2031

        10.3.1. Therapeutics

        10.3.2. Diagnostics

        10.3.3. Research

    10.4. Market Value Forecast, by End-user, 2017–2031

        10.4.1. Hospitals

        10.4.2. Specialty Centers

        10.4.3. Others (research centers, academics, etc.)

    10.5. Market Value Forecast, by Country, 2017–2031

        10.5.1. U.S.

        10.5.2. Canada

    10.6. Market Attractiveness Analysis

        10.6.1. By Product Type

        10.6.2. By Application

        10.6.3. By End-user

        10.6.4. By Country

11. Europe Transcranial Magnetic Stimulators Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Product Type, 2017–2031

        11.2.1. Repetitive TMS

        11.2.2. Deep TMS

        11.2.3. Others

    11.3. Market Value Forecast, by Application, 2017–2031

        11.3.1. Therapeutics

        11.3.2. Diagnostics

        11.3.3. Research

    11.4. Market Value Forecast, by End-user, 2017–2031

        11.4.1. Hospitals

        11.4.2. Specialty Centers

        11.4.3. Others (research centers, academics, etc.)

    11.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Italy

        11.5.5. Spain

        11.5.6. Rest of Europe

    11.6. Market Attractiveness Analysis

        11.6.1. By Product Type

        11.6.2. By Application

        11.6.3. By End-user

        11.6.4. By Country/Sub-region

12. Asia Pacific Transcranial Magnetic Stimulators Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Product Type, 2017–2031

        12.2.1. Repetitive TMS

        12.2.2. Deep TMS

        12.2.3. Others

    12.3. Market Value Forecast, by Application, 2017–2031

        12.3.1. Therapeutics

        12.3.2. Diagnostics

        12.3.3. Research

    12.4. Market Value Forecast, by End-user, 2017–2031

        12.4.1. Hospitals

        12.4.2. Specialty Centers

        12.4.3. Others (research centers, academics, etc.)

    12.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        12.5.1. China

        12.5.2. Japan

        12.5.3. India

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Market Attractiveness Analysis

        12.6.1. By Product Type

        12.6.2. By Application

        12.6.3. By End-user

        12.6.4. By Country/Sub-region

13. Latin America Transcranial Magnetic Stimulators Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Product Type, 2017–2031

        13.2.1. Repetitive TMS

        13.2.2. Deep TMS

        13.2.3. Others

    13.3. Market Value Forecast, by Application, 2017–2031

        13.3.1. Therapeutics

        13.3.2. Diagnostics

        13.3.3. Research

    13.4. Market Value Forecast, by End-user, 2017–2031

        13.4.1. Hospitals

        13.4.2. Specialty Centers

        13.4.3. Others (research centers, academics, etc.)

    13.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Market Attractiveness Analysis

        13.6.1. By Product Type

        13.6.2. By Application

        13.6.3. By End-user

        13.6.4. By Country/Sub-region

14. Middle East & Africa Transcranial Magnetic Stimulators Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Market Value Forecast, by Product Type, 2017–2031

        14.2.1. Repetitive TMS

        14.2.2. Deep TMS

        14.2.3. Others

    14.3. Market Value Forecast, by Application, 2017–2031

        14.3.1. Therapeutics

        14.3.2. Diagnostics

        14.3.3. Research

    14.4. Market Value Forecast, by End-user, 2017–2031

        14.4.1. Hospitals

        14.4.2. Specialty Centers

        14.4.3. Others (research centers, academics, etc.)

    14.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Rest of Middle East & Africa

    14.6. Market Attractiveness Analysis

        14.6.1. By Product Type

        14.6.2. By Application

        14.6.3. By End-user

        14.6.4. By Country/Sub-region

15. Competition Landscape

    15.1. Market Player – Competition Matrix (by tier and size of companies)

    15.2. Market Share Analysis, by Company (2021)

    15.3. Company Profiles

        15.3.1. Neurosoft

            15.3.1.1. Company Overview

            15.3.1.2. Financial Overview

            15.3.1.3. Product Portfolio

            15.3.1.4. Business Strategies

            15.3.1.5. Recent Developments

        15.3.2. Magstim

            15.3.2.1. Company Overview

            15.3.2.2. Financial Overview

            15.3.2.3. Product Portfolio

            15.3.2.4. Business Strategies

            15.3.2.5. Recent Developments

        15.3.3. Nexstim plc

            15.3.3.1. Company Overview

            15.3.3.2. Financial Overview

            15.3.3.3. Product Portfolio

            15.3.3.4. Business Strategies

            15.3.3.5. Recent Developments

        15.3.4. MagVenture, Inc.

            15.3.4.1. Company Overview

            15.3.4.2. Financial Overview

            15.3.4.3. Product Portfolio

            15.3.4.4. Business Strategies

            15.3.4.5. Recent Developments

        15.3.5. BrainsWay

            15.3.5.1. Company Overview

            15.3.5.2. Financial Overview

            15.3.5.3. Product Portfolio

            15.3.5.4. Business Strategies

            15.3.5.5. Recent Developments

        15.3.6. Seber Medical

            15.3.6.1. Company Overview

            15.3.6.2. Financial Overview

            15.3.6.3. Product Portfolio

            15.3.6.4. Business Strategies

            15.3.6.5. Recent Developments

        15.3.7. Soterix Medical, Inc.

            15.3.7.1. Company Overview

            15.3.7.2. Financial Overview

            15.3.7.3. Product Portfolio

            15.3.7.4. Business Strategies

            15.3.7.5. Recent Developments

List of Tables

Table 01: Global Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 02: Global Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 03: Global Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 04: Global Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 05: North America Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 06: North America Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 07: North America Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 08: North America Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 09: Europe Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 10: Europe Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 11: Europe Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 12: Europe Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 13: Asia Pacific Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 14: Asia Pacific Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 15: Asia Pacific Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 16: Asia Pacific Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 17: Latin America Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 18: Latin America Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 19: Latin America Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 20: Latin America Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 21: Middle East & Africa Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 22: Middle East & Africa Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 23: Middle East & Africa Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 24: Middle East & Africa Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

List of Figures

Figure 01: Global Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, 2017–2031

Figure 02: Global Transcranial Magnetic Stimulators Market Value Share Analysis, by Product Type, 2022 and 2031

Figure 03: Global Transcranial Magnetic Stimulators Market Value Share Analysis, by Repetitive TMS, 2022 and 2031

Figure 04: Global Transcranial Magnetic Stimulators Market Value Share Analysis, by Deep TMS, 2022 and 2031

Figure 05: Global Transcranial Magnetic Stimulators Market Value Share Analysis, by Others, 2022 and 2031

Figure 06: Global Transcranial Magnetic Stimulators Market Attractiveness Analysis, by Product Type, 2023–2031

Figure 07: Global Transcranial Magnetic Stimulators Market Value Share Analysis, by Application 2022 and 2031

Figure 08: Global Transcranial Magnetic Stimulators Market Value Share Analysis, by Therapeutics, 2022 and 2031

Figure 09: Global Transcranial Magnetic Stimulators Market Value Share Analysis, by Diagnostics, 2022 and 2031

Figure 10: Global Transcranial Magnetic Stimulators Market Value Share Analysis, by Research, 2022 and 2031

Figure 11: Global Transcranial Magnetic Stimulators Market Attractiveness Analysis, by Application, 2023–2031

Figure 12: Global Transcranial Magnetic Stimulators Market Value Share Analysis, by End-user, 2022 and 2031

Figure 13: Global Transcranial Magnetic Stimulators Market Value Share Analysis, by Hospitals, 2022 and 2031

Figure 14: Global Transcranial Magnetic Stimulators Market Value Share Analysis, by Specialty Centers, 2022 and 2031

Figure 15: Global Transcranial Magnetic Stimulators Market Value Share Analysis, by Others, 2022 and 2031

Figure 16: Global Transcranial Magnetic Stimulators Market Attractiveness Analysis, by End-user, 2023–2031

Figure 17: Global Transcranial Magnetic Stimulators Market Value Share Analysis, by Region, 2022 and 2031

Figure 18: Global Transcranial Magnetic Stimulators Market Attractiveness Analysis, by Region, 2023–2031

Figure 19: North America Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, 2017–2031

Figure 20: North America Transcranial Magnetic Stimulators Market Value Share Analysis, by Product Type, 2022 and 2031

Figure 21: North America Transcranial Magnetic Stimulators Market Attractiveness Analysis, by Product Type, 2023–2031

Figure 22: North America Transcranial Magnetic Stimulators Market Value Share Analysis, by Application, 2022 and 2031

Figure 23: North America Transcranial Magnetic Stimulators Market Attractiveness Analysis, by Application, 2023–2031

Figure 24: North America Transcranial Magnetic Stimulators Market Value Share Analysis, by End-user, 2022 and 2031

Figure 25: North America Transcranial Magnetic Stimulators Market Attractiveness Analysis, by End-user, 2023–2031

Figure 26: North America Transcranial Magnetic Stimulators Market Value Share Analysis, by Country, 2022 and 2031

Figure 27: North America Transcranial Magnetic Stimulators Market Attractiveness Analysis, by Country, 2023–2031

Figure 28: Europe Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, 2017–2031

Figure 29: Europe Transcranial Magnetic Stimulators Market Value Share Analysis, by Product Type, 2022 and 2031

Figure 30: Europe Transcranial Magnetic Stimulators Market Attractiveness Analysis, by Product Type, 2023–2031

Figure 31: Europe Transcranial Magnetic Stimulators Market Value Share Analysis, by Application, 2022 and 2031

Figure 32: Europe Transcranial Magnetic Stimulators Market Attractiveness Analysis, by Application, 2023–2031

Figure 33: Europe Transcranial Magnetic Stimulators Market Value Share Analysis, by End-user, 2022 and 2031

Figure 34: Europe Transcranial Magnetic Stimulators Market Attractiveness Analysis, by End-user, 2023–2031

Figure 35: Europe Transcranial Magnetic Stimulators Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 36: Europe Transcranial Magnetic Stimulators Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 37: Asia Pacific Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, 2017–2031

Figure 38: Asia Pacific Transcranial Magnetic Stimulators Market Value Share Analysis, by Product Type, 2022 and 2031

Figure 39: Asia Pacific Transcranial Magnetic Stimulators Market Attractiveness Analysis, by Product Type, 2023–2031

Figure 40: Asia Pacific Transcranial Magnetic Stimulators Market Value Share Analysis, by Application 2022 and 2031

Figure 41: Asia Pacific Transcranial Magnetic Stimulators Market Attractiveness Analysis, by Application, 2023–2031

Figure 42: Asia Pacific Transcranial Magnetic Stimulators Market Value Share Analysis, by End-user, 2022 and 2031

Figure 43: Asia Pacific Transcranial Magnetic Stimulators Market Attractiveness Analysis, by End-user, 2023–2031

Figure 44: Asia Pacific Transcranial Magnetic Stimulators Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 45: Asia Pacific Transcranial Magnetic Stimulators Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 46: Latin America Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, 2017–2031

Figure 47: Latin America Transcranial Magnetic Stimulators Market Value Share Analysis, by Product Type, 2022 and 2031

Figure 48: Latin America Transcranial Magnetic Stimulators Market Attractiveness Analysis, by Product Type, 2023–2031

Figure 49: Latin America Transcranial Magnetic Stimulators Market Value Share Analysis, by Application, 2022 and 2031

Figure 50: Latin America Transcranial Magnetic Stimulators Market Attractiveness Analysis, by Application, 2023–2031

Figure 51: Latin America Transcranial Magnetic Stimulators Market Value Share Analysis, by End-user, 2022 and 2031

Figure 52: Latin America Transcranial Magnetic Stimulators Market Attractiveness Analysis, by End-user, 2023–2031

Figure 53: Latin America Transcranial Magnetic Stimulators Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 54: Latin America Transcranial Magnetic Stimulators Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 55: Middle East & Africa Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, 2017–2031

Figure 56: Middle East & Africa Transcranial Magnetic Stimulators Market Value Share Analysis, by Product Type, 2022 and 2031

Figure 57: Middle East & Africa Transcranial Magnetic Stimulators Market Attractiveness Analysis, by Product Type, 2023–2031

Figure 58: Middle East & Africa Transcranial Magnetic Stimulators Market Value Share Analysis, by Application, 2022 and 2031

Figure 59: Middle East & Africa Transcranial Magnetic Stimulators Market Attractiveness Analysis, by Application, 2023–2031

Figure 60: Middle East & Africa Transcranial Magnetic Stimulators Market Value Share Analysis, by End-user, 2022 and 2031

Figure 61: Middle East & Africa Transcranial Magnetic Stimulators Market Attractiveness Analysis, by End-user, 2023–2031

Figure 62: Middle East & Africa Transcranial Magnetic Stimulators Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 63: Middle East & Africa Transcranial Magnetic Stimulators Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 64: Global Transcranial Magnetic Stimulators Market Share Analysis, by Company, 2022-2031

Copyright © Transparency Market Research, Inc. All Rights reserved